Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation
Open Access
- 5 May 2011
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 117 (18), 4915-4923
- https://doi.org/10.1182/blood-2010-10-313064
Abstract
Anemia of inflammation develops in settings of chronic inflammatory, infectious, or neoplastic disease. In this highly prevalent form of anemia, inflammatory cytokines, including IL-6, stimulate hepatic expression of hepcidin, which negatively regulates iron bioavailability by inactivating ferroportin. Hepcidin is transcriptionally regulated by IL-6 and bone morphogenetic protein (BMP) signaling. We hypothesized that inhibiting BMP signaling can reduce hepcidin expression and ameliorate hypoferremia and anemia associated with inflammation. In human hepatoma cells, IL-6–induced hepcidin expression, an effect that was inhibited by treatment with a BMP type I receptor inhibitor, LDN-193189, or BMP ligand antagonists noggin and ALK3-Fc. In zebrafish, the induction of hepcidin expression by transgenic expression of IL-6 was also reduced by LDN-193189. In mice, treatment with IL-6 or turpentine increased hepcidin expression and reduced serum iron, effects that were inhibited by LDN-193189 or ALK3-Fc. Chronic turpentine treatment led to microcytic anemia, which was prevented by concurrent administration of LDN-193189 or attenuated when LDN-193189 was administered after anemia was established. Our studies support the concept that BMP and IL-6 act together to regulate iron homeostasis and suggest that inhibition of BMP signaling may be an effective strategy for the treatment of anemia of inflammation.Keywords
This publication has 52 references indexed in Scilit:
- Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in miceJCI Insight, 2009
- BMP6 is a key endogenous regulator of hepcidin expression and iron metabolismNature Genetics, 2009
- Live-animal tracking of individual haematopoietic stem/progenitor cells in their nicheNature, 2008
- BMP type I receptor inhibition reduces heterotopic ossificationNature Medicine, 2008
- Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- The role of STAT, AP-1, E-box and TIEG motifs in the regulation of hepcidin by IL-6 and BMP-9: Lessons from human HAMP and murine Hamp1 and Hamp2 gene promotersBlood Cells, Molecules, and Diseases, 2007
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balanceJCI Insight, 2007
- Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6Proceedings of the National Academy of Sciences of the United States of America, 2006
- Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosisNature Genetics, 2003